NCI Cancer Bulletin for June 28, 2011

June 28, 2011 • Volume 8 / Number 13 Read the NCI Cancer Bulletin The latest issue of the NCI Cancer Bulletin is now available at http://www.cancer.gov/ncicancerbulletin. Keep up to date on the latest research and advances in the prevention, treatment, and understanding of cancer. News Read This Issue Featured Article: New Graphic Tobacco Warning Labels Backed by Research »  Common Gene Mutation Found in Hairy Cell Leukemia »  New Cancer Vaccine Shows Promise against Tumors in Mice »  Researchers Scrutinize Genetic Variants Linked to Melanoma »  Barrett Esophagus May Progress to Cancer Less Often than Thought »  Commentary Read This Issue A Conversation with Dr. Martha Linet on Cell Phone Use and Cancer Risk » In Depth Read This Issue Imaging Boot Camp for Cancer Researchers »  Featured Clinical Trial: Adding Targeted Therapy to Treatment for Esophageal Cancer »  Updates Read This Issue FDA Update »  Cancer.gov Update »  Notes »

NCI Cancer Bulletin for June 14, 2011

June 14, 2011 • Volume 8 / Number 12 Read the NCI Cancer Bulletin The latest issue of the NCI Cancer Bulletin is now available at http://www.cancer.gov/ncicancerbulletin. Keep up to date on the latest research and advances in the prevention, treatment, and understanding of cancer. News Read This Issue Featured Article: New Therapies Offer Much-Needed Options for Patients with Melanoma »  Ovarian Cancer Screening Method Fails to Reduce Deaths from the Disease »  Longer Imatinib Treatment for GIST Improves Survival »  High-Dose Methotrexate Extends Event-Free Survival for Children with Leukemia »  Combining Chemotherapy with Bevacizumab Improves Outcomes for Ovarian Cancer Patients »  Experimental Drug Shrinks Tumors in Rare Sarcoma »  International Study Tests Additional Radiation Therapy for Breast Cancer »  Patient Navigation Leads to Fewer Missed Oncology Appointments »  In Depth Read This Issue Exemestane Substantially Reduces Breast Cancer Risk »  Perfect Match: Unraveling the Origin of XMRV »  Featured Clinical Trial: Combining Second-Line Targeted Therapies for Advanced Kidney Cancer »  Cancer Advocates at ASCO: Connecting for a Cause »  Updates Read This Issue FDA Update »  Notes »